FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914404410> ?p ?o ?g. }

• W2914404410 endingPage "355" @default.
• W2914404410 startingPage "348" @default.
• W2914404410 abstract "L‐carnitine seems to suppress the progression of sarcopenia dose dependently and this was noted to be associated with improvement of hyperammonemia in patients with LC. Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains to be elucidated. We assessed the effects of L‐carnitine on sarcopenia in patients with LC. We retrospectively evaluated 52 patients with LC who were treated with L‐carnitine for more than 3 months between February 2013 and June 2017. Computed tomography was used to measure the cross‐sectional area of the skeletal muscles at the level of the third lumbar vertebra. The relative change in skeletal muscle index (SMI) per year (ΔSMI/year) was computed in each patient. We evaluated the relationship between ΔSMI/year and various parameters, such as age, sex, liver functional reserve, and dose of L‐carnitine. The median ΔSMI/year for all patients was −0.22%. The ΔSMI/year values in Child‐Pugh classes A, B, and C were not significantly different among the three groups. There was no significant relationship between ΔSMI/year and sex, age, body mass index, and sarcopenia. Multivariate analysis showed that only a high dose of L‐carnitine (odds ratio [OR], 4.812; 95% confidence interval [CI], 1.233‐18.784; P = 0.024) was associated with increased muscle mass. The L‐carnitine high‐dose group included a significantly larger number of patients with increased muscle mass compared with the low‐dose group (OR, 3.568; 95% CI, 1.138‐11.185; P = 0.027). Administration of L‐carnitine led to a significant and gradual reduction in serum ammonia levels. Conclusion: L‐carnitine seems to suppress the progression of sarcopenia dose dependently, and this was noted to be associated with the improvement of hyperammonemia in patients with LC." @default.
• W2914404410 created "2019-02-21" @default.
• W2914404410 creator A5003790120 @default.
• W2914404410 creator A5007696404 @default.
• W2914404410 creator A5010040819 @default.
• W2914404410 creator A5018431544 @default.
• W2914404410 creator A5023235157 @default.
• W2914404410 creator A5023958825 @default.
• W2914404410 creator A5024182187 @default.
• W2914404410 creator A5024813969 @default.
• W2914404410 creator A5027695992 @default.
• W2914404410 creator A5032472868 @default.
• W2914404410 creator A5035029873 @default.
• W2914404410 creator A5035036813 @default.
• W2914404410 creator A5037963685 @default.
• W2914404410 creator A5044269436 @default.
• W2914404410 creator A5045968705 @default.
• W2914404410 creator A5050719404 @default.
• W2914404410 creator A5053529562 @default.
• W2914404410 creator A5074699709 @default.
• W2914404410 creator A5081194830 @default.
• W2914404410 creator A5086666355 @default.
• W2914404410 creator A5089353704 @default.
• W2914404410 date "2019-01-22" @default.
• W2914404410 modified "2023-10-11" @default.
• W2914404410 title "Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis" @default.
• W2914404410 cites W1510111120 @default.
• W2914404410 cites W1820460245 @default.
• W2914404410 cites W1918799129 @default.
• W2914404410 cites W1990043320 @default.
• W2914404410 cites W1991870955 @default.
• W2914404410 cites W2010141336 @default.
• W2914404410 cites W2077747404 @default.
• W2914404410 cites W2102083512 @default.
• W2914404410 cites W2111251640 @default.
• W2914404410 cites W2116189773 @default.
• W2914404410 cites W2120073134 @default.
• W2914404410 cites W2127764242 @default.
• W2914404410 cites W2161349877 @default.
• W2914404410 cites W2178214778 @default.
• W2914404410 cites W2274484570 @default.
• W2914404410 cites W2423926234 @default.
• W2914404410 cites W2470715145 @default.
• W2914404410 cites W2492424475 @default.
• W2914404410 cites W2588938745 @default.
• W2914404410 cites W4255015273 @default.
• W2914404410 doi "https://doi.org/10.1002/hep4.1309" @default.
• W2914404410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6396356" @default.
• W2914404410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30859147" @default.
• W2914404410 hasPublicationYear "2019" @default.
• W2914404410 type Work @default.
• W2914404410 sameAs 2914404410 @default.
• W2914404410 citedByCount "38" @default.
• W2914404410 countsByYear W29144044102019 @default.
• W2914404410 countsByYear W29144044102020 @default.
• W2914404410 countsByYear W29144044102021 @default.
• W2914404410 countsByYear W29144044102022 @default.
• W2914404410 countsByYear W29144044102023 @default.
• W2914404410 crossrefType "journal-article" @default.
• W2914404410 hasAuthorship W2914404410A5003790120 @default.
• W2914404410 hasAuthorship W2914404410A5007696404 @default.
• W2914404410 hasAuthorship W2914404410A5010040819 @default.
• W2914404410 hasAuthorship W2914404410A5018431544 @default.
• W2914404410 hasAuthorship W2914404410A5023235157 @default.
• W2914404410 hasAuthorship W2914404410A5023958825 @default.
• W2914404410 hasAuthorship W2914404410A5024182187 @default.
• W2914404410 hasAuthorship W2914404410A5024813969 @default.
• W2914404410 hasAuthorship W2914404410A5027695992 @default.
• W2914404410 hasAuthorship W2914404410A5032472868 @default.
• W2914404410 hasAuthorship W2914404410A5035029873 @default.
• W2914404410 hasAuthorship W2914404410A5035036813 @default.
• W2914404410 hasAuthorship W2914404410A5037963685 @default.
• W2914404410 hasAuthorship W2914404410A5044269436 @default.
• W2914404410 hasAuthorship W2914404410A5045968705 @default.
• W2914404410 hasAuthorship W2914404410A5050719404 @default.
• W2914404410 hasAuthorship W2914404410A5053529562 @default.
• W2914404410 hasAuthorship W2914404410A5074699709 @default.
• W2914404410 hasAuthorship W2914404410A5081194830 @default.
• W2914404410 hasAuthorship W2914404410A5086666355 @default.
• W2914404410 hasAuthorship W2914404410A5089353704 @default.
• W2914404410 hasBestOaLocation W29144044101 @default.
• W2914404410 hasConcept C126322002 @default.
• W2914404410 hasConcept C134018914 @default.
• W2914404410 hasConcept C156957248 @default.
• W2914404410 hasConcept C2776214593 @default.
• W2914404410 hasConcept C2777214474 @default.
• W2914404410 hasConcept C2778435403 @default.
• W2914404410 hasConcept C2780221984 @default.
• W2914404410 hasConcept C2781099255 @default.
• W2914404410 hasConcept C2908967332 @default.
• W2914404410 hasConcept C33872192 @default.
• W2914404410 hasConcept C44249647 @default.
• W2914404410 hasConcept C71924100 @default.
• W2914404410 hasConcept C90924648 @default.
• W2914404410 hasConceptScore W2914404410C126322002 @default.
• W2914404410 hasConceptScore W2914404410C134018914 @default.
• W2914404410 hasConceptScore W2914404410C156957248 @default.
• W2914404410 hasConceptScore W2914404410C2776214593 @default.

• next